Education
About Us
Working with TipRanks
Follow Us
Viva Biotech Holdings (HK:1873)
:1873
RESEARCH TOOLSreports
Total Valuation
Viva Biotech Holdings has a market cap or net worth of HK$3.75B. The enterprise value is ―.
Market CapHK$3.75B
Enterprise Value―
Share Statistics
Viva Biotech Holdings has 2,131,775,400 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,131,775,400
Owned by Insiders―
Owned by Institutions0.01%
Financial Efficiency
Viva Biotech Holdings’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee1.04M
Profits Per Employee-27.12K
Employee Count2,063
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Viva Biotech Holdings is ―. Viva Biotech Holdings’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Viva Biotech Holdings had revenue of 2.16B and earned -116.11M in profits. Earnings per share was -0.14.
Revenue2.16B
Gross Profit738.43M
Operating Income192.68M
Pretax Income-55.95M
Net Income-116.11M
EBITDA391.01M
Earnings Per Share (EPS)-0.14
Cash Flow
In the last 12 months, operating cash flow was 218.29M and capital expenditures -214.42M, giving a free cash flow of 3.86M billion.
Operating Cash Flow218.29M
Free Cash Flow3.86M
Free Cash Flow per Share<0.01
Dividends & Yields
Viva Biotech Holdings pays an annual dividend of HK$0.009, resulting in a dividend yield of ―
Dividend Per ShareHK$0.009
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.26
52-Week Price Change139.73%
50-Day Moving Average1.58
200-Day Moving Average1.02
Relative Strength Index (RSI)62.17
Average Volume (3m)3.57M
Important Dates
Viva Biotech Holdings upcoming earnings date is Aug 28, 2025, TBA Not Confirmed.
Last Earnings DateMar 27, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend DateJun 16, 2021
Financial Position
Viva Biotech Holdings as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Viva Biotech Holdings has paid 43.84M in taxes.
Income Tax43.84M
Effective Tax Rate―
Enterprise Valuation
Viva Biotech Holdings EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Viva Biotech Holdings has HK$1.04B in cash and marketable securities with ¥1.54B in debt, giving a net cash position of HK$505.18M billion.
Cash & Marketable SecuritiesHK$1.04B
Total Debt¥1.54B
Net CashHK$505.18M
Net Cash Per ShareHK$0.24
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Viva Biotech Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-9.75%
EPS Growth Forecast―